NYSE:NTR - Nutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, NTR stock has decreased by 3.2% and is now trading at $30.97. View which stocks have been mosted impacted by Coronavirus.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 6 hold ratings, 14 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Thursday, May 14th 2020. View our earnings forecast for Nutrien.

Nutrien Ltd (NYSE:NTR) issued its quarterly earnings data on Tuesday, February, 18th. The company reported $0.09 earnings per share for the quarter, missing the Thomson Reuters' consensus estimate of $0.28 by $0.19. The firm had revenue of $3.44 billion for the quarter, compared to analyst estimates of $3.36 billion. Nutrien had a net margin of 4.98% and a return on equity of 5.39%. The company's quarterly revenue was down 8.5% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.54 EPS. View Nutrien's earnings history.

Nutrien announced a quarterly dividend on Thursday, February 20th. Shareholders of record on Tuesday, March 31st will be given a dividend of $0.45 per share on Thursday, April 16th. This represents a $1.80 annualized dividend and a dividend yield of 5.81%. The ex-dividend date of this dividend is Monday, March 30th. View Nutrien's dividend history.

Nutrien issued an update on its FY20 earnings guidance on Tuesday, February, 18th. The company provided earnings per share guidance of $1.90-2.60 for the period, compared to the Thomson Reuters consensus estimate of $2.62.

21 equities research analysts have issued 12 month price objectives for Nutrien's stock. Their forecasts range from $44.00 to $70.00. On average, they expect Nutrien's share price to reach $53.76 in the next twelve months. This suggests a possible upside of 73.6% from the stock's current price. View analysts' price targets for Nutrien.

Press coverage about NTR stock has been trending negative this week, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Nutrien earned a media sentiment score of -2.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutNutrien.

Nutrien saw a decrease in short interest in the month of March. As of March 13th, there was short interest totaling 4,418,500 shares, a decrease of 16.6% from the February 27th total of 5,300,000 shares. Based on an average daily volume of 1,710,000 shares, the short-interest ratio is presently 2.6 days. Approximately 0.8% of the company's stock are sold short. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include CF Industries (CF), Scotts Miracle-Gro (SMG), Israel Chemicals (ICL), Mosaic (MOS), Nufarm (NUF), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Wynnstay Group (WYN), Eden Research (EDEN), Evogene (EVGN), Arcadia Biosciences (RKDA), China Green Agriculture (CGA) and Bion Environmental Technologies (BNET).

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include Cimarex Energy (XEC), Bank of America (BAC), General Electric (GE), AT&T (T), Johnson & Johnson (JNJ), Micron Technology (MU), Verizon Communications (VZ), Intel (INTC), NVIDIA (NVDA) and Exxon Mobil (XOM).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of institutional and retail investors. Top institutional shareholders include First Eagle Investment Management LLC (3.90%), Jarislowsky Fraser Ltd (2.30%), Beutel Goodman & Co Ltd. (2.30%), Caisse DE Depot ET Placement DU Quebec (1.87%), Capital Research Global Investors (1.62%) and FMR LLC (1.50%).

NTR stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Capital International Investors, Connor Clark & Lunn Investment Management Ltd., Bank of New York Mellon Corp, Nuveen Asset Management LLC, Goldman Sachs Group Inc., Russell Investments Group Ltd., and Great West Life Assurance Co. Can.

NTR stock was acquired by a variety of institutional investors in the last quarter, including Norges Bank, Letko Brosseau & Associates Inc., Black Creek Investment Management Inc., First Eagle Investment Management LLC, 1832 Asset Management L.P., Hexavest Inc., UBS Asset Management Americas Inc., and Caisse DE Depot ET Placement DU Quebec.

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $30.97.

Nutrien has a market capitalization of $17.68 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 20,300 workers across the globe. View additional information about Nutrien.

The official website for Nutrien is http://www.nutrien.com/.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]